# Executive Final Review — Phase 3: Lifecycle / State Machine Remediation

Date: 2026-08-26
Role: independent final approver / supervisory review
Status: **PASS**

## Scope
Remove control-plane defects identified in Executive Phase 2 without changing strategy weights, entry/exit thresholds, trailing stops, research results, or existing append-only records.

## Remediations completed

### 1. Corporate-action continuity — PASS
Added a shared corporate-action layer for immutable Forward accounting.

Method:
- compare the previously stored close with the current provider's value for the **same prior market date**;
- recognize common forward/reverse split factors;
- use the provider-restated same-date close only for the transition calculation;
- preserve the old append-only record exactly as originally observed;
- persist optional split metadata on the new record;
- fail closed on an unexplained provider restatement or split-like gap rather than guessing a factor from a gap alone.

Verified scenario:
- stored prior close = 100;
- provider later restates the same prior date to 50 after a 2:1 split;
- next open = 52;
- Forward equity produces +4%, not a false -48% loss.

Guarded integration workflow:
- `Wire Corporate Action Controls`
- run `32923384893`
- job `98041276709`
- conclusion: **SUCCESS**

No existing Forward record was rewritten.

### 2. One NYSE calendar for execution/freshness — PASS
Added `lib/market-calendar.ts` and routed legal execution dates through it.

It covers:
- weekends;
- scheduled NYSE holidays;
- New York timezone / DST;
- 09:30 ET execution causality;
- completed-session-based upstream freshness;
- market-data lag measured in NYSE sessions rather than raw wall-clock hours.

The previous branch that could temporarily name a weekday holiday as the execution date has been removed.

Unexpected/ad-hoc exchange closures remain an external residual risk; absence of a dataset bar still prevents an actual ledger execution.

### 3. Semantic regime coverage — PASS
Replaced raw unique-label counts with common regime families:
- `RISK_ON`: strong/weak uptrend;
- `NEUTRAL`: range;
- `RISK_OFF`: high-volatility / downtrend / crisis.

Formal evidence requires:
- at least two semantic families;
- `RISK_ON` observed;
- at least one non-risk-on family observed.

Therefore an uninterrupted bull period cannot pass merely because both “strong uptrend” and “weak uptrend” labels appeared.

The same semantic rule is applied to incumbent and challengers.

### 4. Operational eligibility separated from Promotion merit — PASS
Lifecycle reviews now distinguish:
- `eligible`: operational/evidence integrity sufficient for formal review;
- `promotionMerit`: common-period Pareto relationship to the TQQQ incumbent;
- `promotionSelectable`: eligible and not strictly dominated by the incumbent.

Common-period Pareto dimensions are:
- total return;
- Max DD;
- Sortino;
- Calmar;
- Action Days.

No scalar score or automatic winner was introduced.

A challenger that is operationally valid but strictly worse than TQQQ on every frozen Pareto dimension cannot be submitted for Production approval.

A mixed trade-off remains a human Phase 6 decision.

### 5. Upstream Daily / Phase 5 freshness — PASS
Lifecycle no longer treats a stored `success` flag as permanently current.

The review engine checks:
- workflow result / errors;
- upstream `generatedAt` against completed NYSE sessions;
- market-data date lag against completed NYSE sessions.

Formal/Stronger review requires current upstream data.
Normal accumulating/health operation tolerates at most one completed-session provider lag, which avoids weekend false alarms while still detecting a stopped upstream process.

### 6. Challenger-specific failures no longer create an unnecessary lifecycle dead-end — PASS
Formal logic now distinguishes:
- incumbent/common-baseline failure → Production selection blocked because comparison integrity is invalid;
- one challenger failure → that challenger is excluded, while other healthy alternatives and the incumbent remain reviewable.

### 7. Production Health claims aligned with what is actually measured — PASS
Removed misleading automatic-monitoring claims for metrics that the system does not truly observe.

Automated Production Health now measures:
- integrity;
- upstream data freshness;
- Forward DD against the frozen adverse floor;
- realized Action Days/year.

Health levels:
- integrity/structural integrity defect → Critical;
- stale data, DD breach or >40 Action Days/year → Revalidation Required;
- >24 and <=40 Action Days/year → Watch;
- otherwise Healthy.

The following remain explicit human-review items:
- realized broker execution cost;
- tax;
- FX;
- ETF/index methodology and structural/liquidity changes.

The product must not imply these are automatically measured.

## Tests / operational evidence

### Control primitive audit
- workflow: `Executive Phase 3 Prewire Audit`
- run: `32923182293`
- job: `98040679627`
- conclusion: **SUCCESS**

### Corporate-action integration
- workflow: `Wire Corporate Action Controls`
- run: `32923384893`
- job: `98041276709`
- conclusion: **SUCCESS**

### Lifecycle / control integration
- workflow: `Executive Phase 3 Lifecycle Audit`
- run: `32923612529`
- job: `98041932051`
- conclusion: **SUCCESS**
- lifecycle/control tests: success
- full operational regression: success
- Pages build: success

### Actual autonomous Lifecycle workflow
- run: `32923666782`
- job: `98042096200`
- conclusion: **SUCCESS**
- hardened tests: success
- lifecycle generation: success
- Production-health generation: success
- append-only persistence: success
- Pages build/deploy: success

## Current persisted state after remediation
- lifecycle stage: `ACCUMULATING`
- system decision: `ACCUMULATING`
- user action: `NONE`
- next review: `2027-02-25`
- Production Health: `NOT_IN_PRODUCTION`
- no Production change was made.

The incumbent currently has only a handful of observations. Its raw annualized Action-Day number is therefore statistically meaningless at this point and is not used for the hard cap until a minimum sample is reached. The UI must avoid presenting this tiny-sample annualization as a forecast; that is deferred to Executive Phase 4.

## Strategy invariance
No change was made to:
- VS13 weights/entry/exit/strong thresholds;
- SP_BROAD_TREND weights;
- 13% / 8.6667% frozen stop rules;
- confirm/min-hold/cooldown strategy settings;
- historical Phase 2–4 results;
- existing append-only Forward observations.

## Supervisory decision
**PASS.**
The control-plane defects identified in Executive Phase 2 are remediated sufficiently to proceed to the user-facing operational review.

## Next phase
Executive Phase 4 will audit and remediate the UI from the perspective of a user returning after months away. It must make clear:
- what the user must do now;
- whether the system is healthy;
- why a review decision was reached;
- which systems are merely operationally eligible versus actually Production-selectable;
- common-period Forward trade-offs versus incumbent;
- whether annualized turnover metrics have enough sample;
- that modeled Paper/Forward performance excludes FX, tax and broker-specific realized friction;
- the exact Human Approval path when Phase 6 is reached.
